Aubrey Rankin's Net Worth
$581 Thousand
Who is Aubrey Rankin?
Aubrey Rankin does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Revance Therapeutics, Inc..
SEC CIK
Aubrey Rankin's CIK is 0001818576
Past Insider Trading and Trends
2020 was Aubrey Rankin's most active year for acquiring shares with 5 total transactions. Aubrey Rankin's most active month to acquire stocks was the month of June. 2021 was Aubrey Rankin's most active year for disposing of shares, totalling 2 transactions. Aubrey Rankin's most active month to dispose stocks was the month of July. 2021 saw Aubrey Rankin paying a total of $432,876.00 for 63,445 shares, this is the most they've acquired in one year. In 2021 Aubrey Rankin cashed out on 14,313 shares for a total of $375,431.98, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Revance Therapeutics, Inc. (RVNC) Snapshot price: $6.56
President, Innovation & TechAubrey Rankin owns 94,091 units of Common Stock which is worth $617,236.96.acquired a total of 766,448 shares in Revance Therapeutics, Inc. at a cost of $432,876.00, Aubrey also disposed a total of 15,685 shares of Revance Therapeutics, Inc. equalling to $397,095.86.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.44% | -1.37K |
$15.79 | -$21,663.88 | 94.09K |
Mar 15
| |||
Form 4
| +45.83% | 30K |
$14.43 | $432,876.00 | 95.46K |
Dec 3
| |||
Form 4
| -17.94% | -14.31K |
$26.23 | -$375,431.98 | 65.46K |
Scheduled
|
Aug 15 - Aug 16
| ||
Form 4
| -10.25% | -54.33K |
$30.08 | -$1,632,960.00 | 475.91K |
Scheduled
|
Jul 28
| ||
Form 4
| -13.46% | -55.38K |
$29.72 | -$1,645,953.04 | 355.94K |
Scheduled
|
Jul 26
| ||
Form 4
| -0.00% | -2.00 |
$28.28 | -$56.56 | 411.32K |
Scheduled
|
Apr 5
| ||
Form 4
| -7.45% | -33.12K |
$25.43 | -$842,216.17 | 411.33K |
Scheduled
|
Mar 4
| ||
Form 4
| +17.54% | 11.9K |
—
|
—
| 79.78K |
Feb 2
| |||
Form 4
| -6.93% | -33.12K |
$25.95 | -$859,438.05 | 444.45K |
Scheduled
|
Feb 1
| ||
Form 4
| -6.49% | -33.12K |
$27.82 | -$921,211.61 | 477.56K |
Scheduled
|
Dec 30
| ||
Form 4
| -6.09% | -33.12K |
$23.85 | -$789,888.15 | 510.68K |
Scheduled
|
Nov 30
| ||
Form 4
| -5.74% | -33.12K |
$26.15 | -$865,949.25 | 543.8K |
Scheduled
|
Oct 29
| ||
Form 4
| -5.43% | -33.12K |
$26.18 | -$867,055.42 | 576.92K |
Scheduled
|
Sep 28
| ||
Form 4/A
| +6,283.35% | 667.29K |
—
|
—
| 677.91K |
Jul 23
| |||
Form 4
|
∞
| 667.29K |
—
|
—
| 667.29K |
Jul 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||